KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) Other Working Capital Changes (2016 - 2025)

AbbVie (ABBV) has disclosed Other Working Capital Changes for 14 consecutive years, with $658.0 million as the latest value for Q4 2025.

  • Quarterly Other Working Capital Changes rose 558.0% to $658.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $827.0 million through Dec 2025, up 329.09% year-over-year, with the annual reading at $827.0 million for FY2025, 329.09% up from the prior year.
  • Other Working Capital Changes for Q4 2025 was $658.0 million at AbbVie, up from -$88.0 million in the prior quarter.
  • The five-year high for Other Working Capital Changes was $658.0 million in Q4 2025, with the low at -$452.0 million in Q2 2023.
  • Average Other Working Capital Changes over 5 years is $55.8 million, with a median of $24.5 million recorded in 2022.
  • The sharpest move saw Other Working Capital Changes surged 3100.0% in 2021, then crashed 1384.0% in 2025.
  • Over 5 years, Other Working Capital Changes stood at -$265.0 million in 2021, then skyrocketed by 176.98% to $204.0 million in 2022, then soared by 185.29% to $582.0 million in 2023, then tumbled by 82.82% to $100.0 million in 2024, then skyrocketed by 558.0% to $658.0 million in 2025.
  • According to Business Quant data, Other Working Capital Changes over the past three periods came in at $658.0 million, -$88.0 million, and -$371.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.